A survey reviewed 4,000 responses in the UK, out of which 36% said they had used digital tools to diagnose themselves because ...

It’s clear that CrossFit provides a range of benefits, and recently, researchers set out to explore if it could also reduce ...

A drug that combines an atypical antipsychotic and an SSRI is under FDA review, and if approved will be the first ...

There isn't a cigarette smoker in the world who doesn't know smoking is bad for them. The problems are that nicotine is one of the most highly addic ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

To better catch patients at risk of future overdoses, Ohio's prescription drug monitoring program will begin alerting health ...

Boosting the endocannabinoid 2-AG in the brain can counteract opioid addiction while preserving their pain relief, a Weill ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...